Antibody-drug conjugates of 7-ethyl-10-hydroxycamptothecin: Sacituzumab govitecan and labetuzumab govitecan
Wenjuan Dong(University of Electronic Science and Technology of China), Lin He(University of Electronic Science and Technology of China), Jingying Dai(University of Electronic Science and Technology of China), Jianyou Shi(University of Electronic Science and Technology of China), Ting Yuan(Goethe University Frankfurt), Jiying Yu(University of Electronic Science and Technology of China), Baowen Qi(Chengdu University)
Cited by 31
Related Papers
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
|Signal Transduction and Targeted Therapy|2021|1.7k
Recent advances in the development of protein–protein interactions modulators: mechanisms and clinical trials
|Signal Transduction and Targeted Therapy|2020|893
New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis
|Redox Biology|2018|753
Targeted tumour theranostics in mice via carbon quantum dots structurally mimicking large amino acids
|Nature Biomedical Engineering|2020|409
MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program
|Science Advances|2021|233